ZVRA
Zevra Therapeutics Inc.
10.00$
-1.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | 6.93 | 3.34 | 0.96 | 0.29 | 0.77 | 0.51 | 1.86 | |
| – | – | – | 0.18 | 0.19 | 0.37 | 0.29 | 1.59 | 0.33 | 0.07 | 0.01 | 0.08 | 0.16 | 0.29 | |
| – | – | – | -0.18 | -0.19 | -0.37 | -0.29 | 5.34 | 3.01 | 0.89 | 0.29 | 0.69 | 0.35 | 1.57 | |
| 20.14 | 6.89 | 15.49 | 30.25 | 22.44 | 22.49 | 37.26 | 10.48 | 2.22 | 0.34 | 0.57 | 1.12 | 0.91 | 0.22 | |
| 15.75 | 2.76 | 5.88 | 19.29 | 15.35 | 13.95 | 11.16 | 5.84 | 1.99 | 0.29 | 0.44 | 0.70 | 1.19 | 1.36 | |
| 0.96 | 9.65 | 21.38 | 49.54 | 37.79 | 36.43 | 48.43 | 16.31 | 4.42 | 0.63 | 1.52 | 2.09 | 2.23 | 1.65 | |
| -35.89 | -9.65 | -21.38 | -49.54 | -41.08 | -36.43 | -49.89 | -10.97 | -1.41 | 0.26 | -1.23 | -1.40 | -1.88 | -0.07 | |
| – | 0.32 | 3.53 | 5.80 | 7.81 | 8.01 | 6.32 | 3.51 | 1.78 | 0.01 | 0.01 | 0.04 | 0.16 | 0.14 | |
| -0.72 | -10.73 | -31.82 | -118.64 | -18.12 | -47.42 | -50.50 | -13.24 | -3.21 | -0.29 | -0.78 | -1.30 | -1.95 | 1.51 | |
| -0.25 | -0.04 | -0.03 | 0.06 | -0.02 | -0.05 | -0.11 | -0.01 | -0.01 | 0.00 | 0.00 | – | 0.33 | 0.06 | |
| -0.47 | -10.69 | -31.79 | -118.69 | -18.10 | -47.37 | -50.39 | -13.23 | -3.21 | -0.29 | -0.78 | -1.30 | -2.28 | 1.45 | |
| 2.48 | -9.51 | -21.28 | -49.35 | -37.59 | -36.07 | -48.14 | -9.56 | -1.36 | -0.26 | -0.74 | -1.23 | -1.65 | 1.72 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.